First Trust Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $192M | Buy |
656,353
+117,113
| +22% | +$38.5M | 0.14% | 183 |
|
|
2025
Q4 | $189M | Sell |
539,240
-157,028
| -23% | -$53.1M | 0.14% | 180 |
|
|
2025
Q3 | $225M | Sell |
696,268
-160,632
| -19% | -$50M | 0.17% | 146 |
|
|
2025
Q2 | $333M | Buy |
856,900
+155,304
| +22% | +$62.5M | 0.27% | 78 |
|
|
2025
Q1 | $305M | Sell |
701,596
-565,800
| -45% | -$227M | 0.27% | 79 |
|
|
2024
Q4 | $468M | Buy |
1,267,396
+414,989
| +49% | +$174M | 0.41% | 36 |
|
|
2024
Q3 | $443M | Buy |
852,407
+45,137
| +6% | +$24.1M | 0.42% | 37 |
|
|
2024
Q2 | $437M | Sell |
807,270
-30,029
| -4% | -$15.9M | 0.45% | 33 |
|
|
2024
Q1 | $434M | Buy |
837,299
+380,068
| +83% | +$189M | 0.44% | 33 |
|
|
2023
Q4 | $216M | Buy |
457,231
+5,436
| +1% | +$2.51M | 0.24% | 130 |
|
|
2023
Q3 | $197M | Sell |
451,795
-382,684
| -46% | -$174M | 0.23% | 120 |
|
|
2023
Q2 | $371M | Buy |
834,479
+61,055
| +8% | +$28.2M | 0.42% | 28 |
|
|
2023
Q1 | $356M | Buy |
773,424
+52,902
| +7% | +$25.2M | 0.41% | 36 |
|
|
2022
Q4 | $370M | Sell |
720,522
-14,074
| -2% | -$7.15M | 0.44% | 26 |
|
|
2022
Q3 | $334M | Sell |
734,596
-26,227
| -3% | -$12.5M | 0.43% | 26 |
|
|
2022
Q2 | $367M | Buy |
760,823
+287,554
| +61% | +$142M | 0.45% | 24 |
|
|
2022
Q1 | $232M | Buy |
473,269
+66,880
| +16% | +$30.6M | 0.24% | 112 |
|
|
2021
Q4 | $188M | Buy |
406,389
+22,559
| +6% | +$9.49M | 0.18% | 153 |
|
|
2021
Q3 | $143M | Sell |
383,830
-4,881
| -1% | -$1.85M | 0.15% | 177 |
|
|
2021
Q2 | $148M | Buy |
388,711
+100,310
| +35% | +$38.3M | 0.16% | 156 |
|
|
2021
Q1 | $104M | Buy |
288,401
+38,359
| +15% | +$12.3M | 0.13% | 204 |
|
|
2020
Q4 | $80.3M | Buy |
250,042
+49,329
| +25% | +$15.1M | 0.11% | 243 |
|
|
2020
Q3 | $53.9M | Sell |
200,713
-8,180
| -4% | -$2.2M | 0.09% | 325 |
|
|
2020
Q2 | $54.9M | Sell |
208,893
-6,726
| -3% | -$1.79M | 0.1% | 270 |
|
|
2020
Q1 | $49M | Buy |
215,619
+43,770
| +25% | +$11.9M | 0.11% | 273 |
|
|
2019
Q4 | $51.9M | Buy |
171,849
+51,544
| +43% | +$14.2M | 0.09% | 335 |
|
|
2019
Q3 | $28.9M | Buy |
120,305
+42,875
| +55% | +$11.7M | 0.05% | 468 |
|
|
2019
Q2 | $21.9M | Sell |
77,430
-185,672
| -71% | -$50.7M | 0.04% | 543 |
|
|
2019
Q1 | $75.5M | Buy |
263,102
+42,424
| +19% | +$12.3M | 0.15% | 168 |
|
|
2018
Q4 | $58M | Buy |
220,678
+87,156
| +65% | +$24M | 0.14% | 175 |
|
|
2018
Q3 | $36.6M | Sell |
133,522
-2,829
| -2% | -$734K | 0.07% | 346 |
|
|
2018
Q2 | $32.5M | Buy |
136,351
+17,034
| +14% | +$3.94M | 0.07% | 349 |
|
|
2018
Q1 | $26.2M | Sell |
119,317
-47,508
| -28% | -$11.2M | 0.06% | 418 |
|
|
2017
Q4 | $37.5M | Buy |
166,825
+32,512
| +24% | +$6.92M | 0.09% | 281 |
|
|
2017
Q3 | $25.5M | Sell |
134,313
-104,227
| -44% | -$19.8M | 0.07% | 377 |
|
|
2017
Q2 | $44.9M | Buy |
238,540
+10,864
| +5% | +$1.95M | 0.12% | 190 |
|
|
2017
Q1 | $37.7M | Sell |
227,676
-21,679
| -9% | -$3.45M | 0.1% | 216 |
|
|
2016
Q4 | $35.9M | Sell |
249,355
-68,411
| -22% | -$9.16M | 0.11% | 210 |
|
|
2016
Q3 | $39.8M | Buy |
317,766
+92,379
| +41% | +$11.9M | 0.12% | 187 |
|
|
2016
Q2 | $29.6M | Buy |
225,387
+786
| +0.3% | +$108K | 0.09% | 262 |
|
|
2016
Q1 | $31.2M | Sell |
224,601
-268,599
| -54% | -$35.9M | 0.1% | 249 |
|
|
2015
Q4 | $68.8M | Sell |
493,200
-119,496
| -20% | -$16.5M | 0.18% | 125 |
|
|
2015
Q3 | $85.8M | Buy |
612,696
+347,000
| +131% | +$52.1M | 0.25% | 86 |
|
|
2015
Q2 | $43.6M | Sell |
265,696
-160,396
| -38% | -$25.6M | 0.11% | 183 |
|
|
2015
Q1 | $65.8M | Sell |
426,092
-25,198
| -6% | -$3.59M | 0.19% | 108 |
|
|
2014
Q4 | $56.7M | Sell |
451,290
-59,545
| -12% | -$7.36M | 0.19% | 122 |
|
|
2014
Q3 | $61.1M | Sell |
510,835
-86,969
| -15% | -$9.98M | 0.24% | 79 |
|
|
2014
Q2 | $64.3M | Buy |
597,804
+30,415
| +5% | +$3.13M | 0.27% | 56 |
|
|
2014
Q1 | $56.5M | Buy |
567,389
+116,337
| +26% | +$10.5M | 0.25% | 56 |
|
|
2013
Q4 | $41.7M | Buy |
451,052
+67,761
| +18% | +$6.02M | 0.2% | 92 |
|
|
2013
Q3 | $32M | Sell |
383,291
-24,277
| -6% | -$2.08M | 0.17% | 124 |
|
|
2013
Q2 | $33.4M | Buy |
+407,568
| New | +$30.5M | 0.22% | 89 |
|
Other funds holding ELV
VCM
VPM
First Trust Advisors's ELV Position: Q1 2026 in Review
First Trust Advisors increased its Elevance Health (ELV) stake by 22% in Q1 2026, buying an estimated $38.5M and bringing the position to 656,353 shares worth $192M. The position accounts for 0.14% of the portfolio, ranked #183.
First Trust Advisors first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $468M in Q4 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- First Trust Advisors held 656,353 shares of Elevance Health worth $192M as of Q1 2026.
- First Trust Advisors bought 117,113 Elevance Health shares in Q1 2026, an estimated $38.5M.
- Elevance Health made up 0.14% of First Trust Advisors's portfolio in Q1 2026, its #183 holding.
- First Trust Advisors first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- First Trust Advisors's Elevance Health position peaked at $468M in Q4 2024.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on First Trust Advisors's 13F filing for Q1 2026, filed 13 May 2026.